Search - tctmd.com

Displaying 21 - 40 of 416

Sort: Relevancy | Date

Presentation TCT 2025

TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

Presenter: Aditya Mantha

October 26, 2025

Presentation TCT 2025

TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE

Presenter: Prakriti Gaba

October 26, 2025

Presentation TCT 2025

TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents

Presenter: Haseeb Ur Rahman

October 26, 2025

Presentation TCT 2025

TCT 334: Investigating the Safety and Efficacy of HydroDynamic Contrast Recanalization in In-Stent Restenosis-Related Coronary Chronic Total Occlusions

Presenter: Akshitha Yarrabothula

October 26, 2025

Presentation TCT 2025

TCT 177: Procedural Success of Excimer Laser Coronary Angioplasty in the Setting of In-stent Restenosis: Meta Analyses

Presenter: Jasvindar Singh

October 26, 2025

Presentation TCT 2025

A Novel Drug-Eluting Retrievable Scaffold for Coronary In-Stent Restenosis (Reflow Medical): Early First in Human Results

Presenter: Scott Harding

October 26, 2025

Presentation TCT 2025

Everolimus-Coated Balloon Intervention for Patients with In-Stent Restenosis: 3-Year Clinical Results

Presenter: Fernando Alfonso

October 26, 2025

Presentation TCT 2025

TCT 1667: Acute Coronary Syndrome due to Ostial Stent Underexpansion and Acute In-Stent Restenosis

Presenter: Shaan Ali Ahmed

October 25, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Conference News EuroPCR 2025

IVL Effective in Severely Calcified Lesions, Especially in Women

Yael L. Maxwell

May 22, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

Presentation CTO 2025

Subintimal Plaque Modification and Neo-Lumen Creation for Management of Resistant In-Stent Restenosis

Presenter: Omar Abdelhai

February 28, 2025

Presentation CTO 2025

Hydrodynamic Contrast Recanalization of Chronically Occluded In-stent Restenosis

Presenter: Brian Li

February 28, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

Presentation TCT 2024

TCT 500: Long-term Outcomes and Predictor of Target Lesion Revascularization the Patients After Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

Presenter: Ikuta Akihiro

October 29, 2024

Advertisement

TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE

TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents

TCT 334: Investigating the Safety and Efficacy of HydroDynamic Contrast Recanalization in In-Stent Restenosis-Related Coronary Chronic Total Occlusions

TCT 177: Procedural Success of Excimer Laser Coronary Angioplasty in the Setting of In-stent Restenosis: Meta Analyses

A Novel Drug-Eluting Retrievable Scaffold for Coronary In-Stent Restenosis (Reflow Medical): Early First in Human Results

Everolimus-Coated Balloon Intervention for Patients with In-Stent Restenosis: 3-Year Clinical Results

TCT 1667: Acute Coronary Syndrome due to Ostial Stent Underexpansion and Acute In-Stent Restenosis

What’s Going to Be Hot at TCT 2025

August 2025 Dispatch for the CV Team

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

IVL Effective in Severely Calcified Lesions, Especially in Women

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Subintimal Plaque Modification and Neo-Lumen Creation for Management of Resistant In-Stent Restenosis

Hydrodynamic Contrast Recanalization of Chronically Occluded In-stent Restenosis

Top Coronary Artery Disease News in 2024

Reimbursement Issues Seem to Be Holding Renal Denervation Back

TCT 500: Long-term Outcomes and Predictor of Target Lesion Revascularization the Patients After Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content